SciELO - Scientific Electronic Library Online

 
vol.34 número2La glutamina oral reduce el daño miocárdico tras revascularización coronaria bajo derivación cardiopulmonar. Un ensayo clínico aleatorizadoAporte de hierro y zinc bioaccesible a la dieta de niños hondureños menores de 24 meses índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Nutr. Hosp. vol.34 no.2 Madrid mar./abr. 2017

http://dx.doi.org/10.20960/nh.788 

Trabajos originales

Intestinal dysfunction in the critical trauma patients. An early and frequent event

Disfunción intestinal en los traumatizados críticos. Un suceso precoz y frecuente

Beatriz Pinto-da-Costa1  2  , Paulo Martins2  3  , Carla Veríssimo2  4  , Marta Simões2  4  , Marisa Tomé1  , Manuela Grazina2  4  , Jorge Pimentel2  3  , Francisco Castro-Sousa1  2 

1A Surgical Department. Hospitais da Universidade de Coimbra. Centro Hospitalar e Universitário de Coimbra. Coimbra, Portugal

2Faculty of Medicine. University of Coimbra. Coimbra, Portugal.

3Intensive Medicine Department. Centro Hospitalar e Universitário de Coimbra. Coimbra, Portugal.

4Genetic Biochemistry Department. Center for Neurosciences and Cellular Biology of Coimbra University. University of Coimbra. Coimbra, Portugal.

Abstract

Background:

Small-bowel dysfunction exerts a relevant prognostic impact in the critically ill patients. Citrullinemia has been used in the evaluation of the intestinal function and it is considered an objective parameter of the functional enterocyte mass. Present study proposes to determine the intestinal dysfunction prevalence and the citrullinemia kinetic profile in severe trauma patients and to investigate its correlation with severity indicators and clinical outcome.

Methods:

A prospective study including 23 critical trauma patients was performed. Aminoacidemias were quantified, by ion exchange chromatography, at the admission and at the first and third days. Severity and outcome parameters were registered.

Results:

In severe trauma patients, severe hypocitrullinemia (< 20 μmol/L) prevalence at admission was high (69.6%) and mean citrullinemia was low (19.5 ± 11.1 μmol/L). Baseline citrullinemia was inversely and significantly correlated with shock index (r = -55.1%, p = 0.008) and extent of invasive ventilation support (r = -42.7%, p = 0.042). Citrullinemia < 13.7 μmol/L at admission, observed in 17.4% of patients, was associated with higher shock index (1.27 ± 0.10 versus 0.75 ± 0.18, p = 0.0001) and longer duration of invasive ventilation support (20.3 ± 7 versus 11.2 ± 7.1 days, p = 0.029) and intensive care unit stay (22 ± 5.9 versus 12.2 ± 8.8 days, p = 0.048). A citrullinemia decrease in the first day after admittance superior to 12.7% constituted a significant predictive factor of in-hospital mortality (75 versus 14.3%, p = 0.044; odds ratio = 7.8; accuracy = 65.2%; specificity = 92.3%; negative predictive value = 85.7%] and lower actuarial survival (69.8 ± 41.6 versus 278.1 ± 37.4 days, p = 0.034).

Conclusions:

Those results confirm the high prevalence and the prognostic relevance of hypocitrullinemia, considered a biomarker of enterocyte dysfunction, in severe trauma patients.

Key words: Citrulline; Intestinal dysfunction; Trauma; Mortality; Critically ill patients

Resumen

Introducción:

la disfunción intestinal ejerce un importante impacto pronóstico en los pacientes críticamente enfermos. La citrulinemia se ha utilizado en la evaluación de la función intestinal. El presente estudio propone determinar la prevalencia de la disfunción intestinal y el perfil cinético de la citrulinemia en enfermos con trauma grave e investigar su correlación con la gravedad y la evolución clínica.

Métodos:

se realizó un estudio prospectivo incluyendo 23 pacientes traumatizados críticos. Las aminoacidemias se cuantificaron, mediante cromatografía de intercambio iónico, en la admisión y en el primer y tercer días. Se registraron los parámetros de gravedad y evolución clínica.

Resultados:

la prevalencia de la hipocitrulinemia grave (< 20 μmol/L) en la admisión fue alta (69,6%) y citrulinemia media fue baja (19,5 ± 11,1 μmol/L). La citrulinemia basal se correlacionó con el índice de choque (r = -55,1%, p = 0,008) y la duración de asistencia ventilatoria invasiva (r = -42,7%, p = 0,042). La citrulinemia < 13,7 μmol/L en la admisión se asoció con mayor índice de choque (1,27 ± 0,1 versus 0,75 ± 0,18, p = 0,0001) y mayor duración de ventilación invasiva (20,3 ± 7 versus 11,2 ± 7,1 días, p = 0,029) y hospitalización en la unidad de cuidados intensivos (22 ± 5,9 versus 12,2 ± 8,8 días, p = 0,048). La disminución de la citrulinemia en el primer día superior al 12,7% fue un factor predictor significativo de mortalidad hospitalaria (75 versus 14,3%, p = 0,044; odds ratio = 7,8; precisión = 65,2%; especificidad = 92,3%; valor predictivo negativo = 85,7%] y menor supervivencia actuarial (69,8 ± 41,6 versus 278,1 ± 37,4 días, p = 0,034).

Conclusiones:

estos resultados confirman la alta prevalencia y la importancia pronóstica de la hipocitrulinemia, biomarcador de disfunción enterocitaria, en los pacientes con trauma severo.

Palabras clave: Citrulina; Disfunción intestinal; Trauma; Mortalidad; Pacientes críticos

INTRODUCTION

The small-bowel accomplishes complex and intricate absorptive, digestive, defense, neuromotor, endocrine and metabolic functions. It is the largest endocrine organ and produces peptides that regulate the metabolism of glucose; appetite and food ingestion; gastric, biliary and pancreatic secretions; gastrointestinal motility and immune function (1,2). The Gut-associated Lymphoid Tissue (GALT) is one of the largest lymphoid organs, containing up to 70% of the body's total number of immune cells, and the inductor for the mucosal-associated lymphoid tissue (MALT) 2,3. Furthermore, small-bowel plays a central role in pathophysiology of the systemic inflammatory response and multiple organ dysfunction syndromes in the critical illness 4.

The definition of acute gastrointestinal injury in the critically ill patients remains challenging 5,6. Nevertheless, small-bowel dysfunction is considered to exert a relevant adverse impact on the prognosis and to be frequently unrecognized in this context 6,7. As previously reported, 60.2% of critically ill patients evidenced one or more gastrointestinal symptoms during the first week of intensive care unit (ICU) admittance, including high gastric residual volumes, absent bowel sounds, vomiting or regurgitation, diarrhea, bowel distention and gastrointestinal bleeding 8; and 58.3% developed enteral nutrition intolerance 9. Reintam A et al. 8 verified that the gastrointestinal failure, defined by the association of three or more gastrointestinal symptoms on the first day in ICU, was present in 4.8% of the patients and was independently associated with a threefold increased risk of mortality. In their study, during the first week in ICU, gastrointestinal failure occurred in 6.4% of patients and was associated with higher 28-day mortality (62.5 versus 28.9%, p = 0.001) (8). According Reintam A et al. 9, the development of gastrointestinal failure, described by a five-grade scoring system based on food intolerance and intra-abdominal hypertension, in the first three days of the ICU stay, was an independent risk factor for ICU and 90-day mortality.

Citrulline is a non-protein amino acid that results from the enterocyte mitochondrial metabolism of glutamine, particularly in the proximal small bowel, at the upper and medium part of the villi 10,11. Citrulline participates in the adaptation to the variations of the protein ingestion and in the nitric oxide production 10,12. After its synthesis, regulated by pyrroline 5-carboxylate synthase, an enzyme almost exclusive of the enterocytes, citrulline is released in the portal circulation and converted to arginine in the kidneys. Therefore, the intestine represents the main source of circulating citrulline 10,11.

Citrullinemia has been recognized an objective, quantitative, reproducible and simple parameter of the functional enterocyte mass 10,12,13 and proposed as a biomarker of acute intestinal failure in the critically ill patients 6,12,13.

The present study intends to determine the prevalence of intestinal dysfunction and the kinetic profile of citrullinemia in severe trauma patients and to evaluate its correlation with the severity indicators and clinical outcome.

METHODS

A prospective observational cohort study of adult critical trauma patients admitted in the Intensive Care Unit (ICU) of a tertiary university hospital was accomplished between October 2013 and April 2014. Recruitment of trauma patients was based on the Intensive Care Society definition of critically illness 14 and the prediction of an ICU length of stay not inferior to three days. Rejection factors were pregnancy, lactation, acquired immunodeficiency syndrome, renal insufficiency (creatininemia ≥ 2 mg/dL), acute liver failure (conforming to previous definitions) 15,16, amino acid metabolism diseases, chronic gut disorders and previous enterectomy.

Study was ratified by the institution's ethics committee and adhered to the principles of the Helsinki's declaration 17.

Patients' age, gender and type of admission (primary or after initial treatment on other hospital) were registered. Severity scores were recorded at the admittance, including Acute Physiology and Chronic Health Evaluation II (APACHE II) score 18, Simplified Acute Physiology Score II (SAPS II) 19, Sequential Organ Failure Assessment (SOFA) score 20, Injury Severity Score 21, Revised Trauma Score 22 and Shock Index 23. Mechanical ventilation, erythrocytes transfusions, catecholamines support, renal substitution therapy, surgical interventions and artificial feeding were listed, as well as, glutamine exogenous supplementation. Regular regimens were used in enteral nutrition; glutamine (0.2-0.4 mg/kg/day) was provided intravenously in patients on parenteral nutrition.

Assessment was undertaken at the time of admittance in the ICU, at the first and the third days, with measurement of amino acid plasma levels (citrulline, ornithine, proline, arginine, glutamine, alanine, glutamic acid, leucine and isoleucine) and routine laboratory tests (including blood gases analysis and arterial lactate level).

Plasma levels of amino acids were quantified by ion exchange chromatography in a high-pressure system (Biochrom 30 analyzer). Plasma was obtained from blood drawn in ethilenediaminotetraacetic acid, by centrifugation at 4,000 g, during 10 minutes, and refrigerated at 4 °C; samples were prepared with 12% ditiotreitol, five to 10 minutes, deproteinized with sulfosalicilic acid, 60 minutes at room temperature and, after separation of the sediment by centrifugation, were filtered and stored at -20 °C for posterior processing.

Primary targets included in-hospital mortality rate and actuarial survival. Secondary goals were health care-associated infections rate 24, extent of invasive ventilation support, hospital and ICU lengths of stay and performance status at the last examination (as stated by the Karnofsky index) 25. The criteria of the health care-associated infections in the acute care setting of the National Healthcare Safety Network (NSHN), Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA were considered 24.

Statistical analysis was completed with SPSS Software version 18.0 for Windows (SPSS Inc., Chicago, IL, USA) applying Qui-square, Student's t, Kaplan Meier and log rank tests, Pearson's correlations and Receiver Operating Characteristic

(ROC) curves. Significant differences were regarded for p value < 0.05. Data were expressed as n (%) or mean ± standard deviation (SD).

RESULTS

Twenty-three critical trauma patients were included, 78.3% of male gender, with a mean age of 48.8 ± 17.8 (21-82) years-old and 78.3% primarily admitted. Mean values of APACHE II, SAPS II and SOFA scores were 19.4 ± 5.5 (10-32), 41.3 ± 12.2 (20-78) and 6.9 ± 3.2 (2-10), respectively; Shock Index, Injury Severity Score and Revised Trauma Score were 0.82 ± 0.25 (0.31-1.4), 47.9 ± 18.5 (27-75) and 5.9 ± 1.3 (3.6-7.6). All the patients were submitted to invasive ventilation and enteral nutrition, 16 to cathecolamines support, 14 to erythrocytes transfusion, 14 to surgical interventions and one to parenteral nutrition. ICU, hospital and global mortality rates were 17.4%, 26.1% and 43.5%, respectively. Health care-associated infections rate was 87%. Mean duration of ventilation support was 12.7 ± 7.8 (2-27) days; ICU and hospital extent of stay were 13.9 ± 9.1 (3-52) and 29.4 ± 21.9 (5-95) days. After a mean follow-up of 7.4 ± 3.1 (2.3-12.2) months, actuarial survival was 229.2 ± 32.9 (95%CI 164.7-293.8) days. Karnofsky's index at the moment of the last examination was 69 ± 17.3 (40-90).

Analysis of plasma amino acid profile was completed in all patients at the ICU admission; in 18 both at the admission and the first day; 12 patients fulfilled the three points of assessment.

In critical trauma patients, mean value of citrullinemia at the moment of admission was low [19.5±11.1 (4-60.3) μmol/L] and increased, although not significantly, during the first three days in the ICU [20.2 ± 10.6 (5.6-49.2) μmol/L in the first day and 24.8 ± 15.2 (13.8-56.6) μmol/L in the third day] (Fig. 1). Severe hypocitrullinemia (< 20 μmol/L) prevalence was high (n = 16; 69.6%). At admittance, citrullinemia was not significantly correlated with the plasma concentrations of other amino acids, including glutamine, arginine, ornithine and proline. Baseline citrullinemia was inversely and significantly correlated with shock index [Pearson's correlation coefficient (r) = -55.1%, p = 0.008] and length of invasive ventilation support (r = -42.7%, p = 0.042) (Fig. 2). No significant connection was observed between citrullinemia and severity indexes. Citrullinemia < 13.7 μmol/L at admission, documented in 17.4% of patients, was associated with higher shock index (1.27 ± 0.10 versus 0.75 ± 0.18, p = 0.0001) and longer duration of invasive ventilation support (20.3 ± 7 versus 11.2 ± 7.1 days, p = 0.029) and of intensive care unit stay (22 ± 5.9 versus 12.2 ± 8.8 days, p = 0.048) (Table I). In univariate analysis, a citrullinemia reduction at the first day after admission (∆Citrullinemia1) superior to 12.7%, verified in 17.4% of patients, constituted a significant predictive factor of in-hospital mortality [75 versus 14.3%, p = 0.044; odds ratio = 7.8 (95%CI 1.04-58.8); accuracy = 65.2%; sensitivity = 60%; specificity = 92.3%; positive predictive value = 75%; negative predictive value = 85.7%] and lower actuarial survival (69.8 ± 41.6 versus 278.1 ± 37.4 days, p = 0.034) (Fig. 3 and Fig. 4).

Figure 1 Mean plasma concentrations of citrulline, glutamine, ornithine, proline and arginine in critical trauma patients (n = 23) at the moment of admission in the intensive care unit (ICU), at the first and the third days. *Plasma levels × 10-1; **Mean values of a cohort of fasting healthy individuals (n = 100) were used for comparison (26). 

Figure 2 Correlations between citrullinemia at the admission and Shock Index (r = -55.1%, p = 0.008) and invasive ventilation support duration (r = -42.7%, p = 0.042) in severe trauma patients (n = 23). Pearson’s correlation test and coefficient (r) were used. Shock index was calculated as the ratio between the first recorded heart rate and systolic blood pressure and its normal value is considered 0.7 or less (23). °Citrullinemia ≥ 13.7 μmol/L, • Glutaminemia < 13.7 μmol/L. 

Table I Relation between citrullinemia at the admission and critical trauma patients' characteristics, severity scores and outcome parameters (n = 23) 

Data expressed as number (%) or mean ± standard deviation. APACHE II: Acute Physiology and Chronic Health Evaluation II; Health CA infections: health care-associated infections; SAPS II: Simplified Acute Physiology Score II; SD: standard deviation; SOFA: Sequential Organ Failure Assessment; vs.: versus; statistically n.s.: statistically not significant. at-Student and Qui-square tests.

Figure 3 Variation of citrullinemia between the moment of admission and the first day at the intensive care unit (∆Citrullinemia1) in critical trauma patients (n = 23) according in-hospital mortality. • ∆Citrullinemia1 ≥ -12.7%, • ∆Citrullinemia1 < -12.7% 

Figure 4 Actuarial survival curves in critical trauma patients (n = 23) admitted in the intensive care unit according the variation of citrullinemia between the moment of admission and the first day at the intensive care unit (∆Citrullinemia1) (Kaplan-Meyer curves and log rank test). 

DISCUSSION

In present series, acute intestinal dysfunction, defined as the reduction of enterocyte function and quantified by the citrulline plasma concentration, developed frequently and early after severe trauma. Approximately 69.6% of patients demonstrated citrullinemia levels under 20 μmol/L at the time of ICU admission, in consonance with the observed by other authors (50 to 68%) 6. Mean citrulline plasma levels of critical trauma patients at the admission on the ICU were lower than those of described in the literature for fasting healthy individuals 26.

Baseline citrullinemia demonstrated a significant inverse and moderate correlation with the shock index, in agreement with the pathophysiology of gut failure in critically ill patients; in fact, ischemia is one of the leading mechanisms of loss of enterocyte integrity in this context 6. Intestinal mucosa is extremely sensitive to ischemia-reperfusion injury with induction of epithelial apoptosis, disruption of barrier integrity and increase of permeability 27.

According present data and in agreement with other studies 6, an association between citrullinemia values and outcome parameters was demonstrated. Citrullinemia was inversely related with duration of invasive ventilation and baseline levels of citrulline below 13.7 μmol/L were significantly associated with prolonged mechanical ventilation and ICU stay. Furthermore, a reduction of citrulline levels higher than 12.7% during the first day after admission constituted a risk factor of in-hospital mortality, with high specificity and negative predictive value, and of lower actuarial survival. Citrullinemia threshold observed in present study is in consonance with those referred in the literature 6.

Intestinal mucosal barrier integrity is compromised in the critical illness, with increase of epithelial apoptosis and permeability.

Autodigestion and release of toxic intestine-derived mediators through the mesenteric lymphatics induces inflammatory, cytotoxic and proteolytic injuries in distant organs, including the lung 28 .

Citrullinemia has been related with objective intestinal dysfunction, including histological evidences of damage 29, systemic inflammation parameters 7,30-33, bacterial translocation 30,34 and clinical manifestations of intestinal dysfunction, such as ileus, diarrhea and bleeding 6,35.

Piton G et al. 31 verified that citrullinemia plasma concentrations ≤ 10 μmol/L at the first 24 hours, present in 44% of critically ill patients, were associated with higher nosocomial infection rates and constituted independent risk factors of 28 days-mortality. In another study, citrullinemia levels ≤ 12.2 μmol/L and plasma concentrations of intestinal-fatty acid binding protein (an enterocyte damage marker) ≥ 355 pg/mL at the moment of ICU admission were independently related with higher 28 days-mortality in multivariate analysis 7. Plasma citrulline concentration less than or equal to 10 µmol/L at admission to the ICU was associated with higher intra-abdominal pressure, higher plasma C-reactive protein concentration, and more frequent antibiotic use 7.

Hypocitrullinemia < 15 μmol/L was connected with the development of clinical manifestations of intestinal dysfunction, including higher residual gastric volume, ileus, among others 35.

Although citrullinemia has been proposed for the evaluation of the intestinal function in the critically illness, its prognostic value requires further validation. In fact, in this context, limitations of citrullinemia include the susceptibility to the interferences of renal insufficiency, the reduced glutamine bioavailability and the increase of extra-intestinal synthesis of citrulline from arginine in the systemic inflammatory syndrome 6,12,13.

Limitations of present series included the single-center character, small number of studied patients and high severity scores.

Present findings confirm the precocious development, high prevalence and prognostic relevance of hypocitrullinemia, considered a biomarker of intestinal dysfunction, in severe trauma patients. Evaluation of intestinal function may allow the implementation of prophylactic and therapeutic strategies of intestinal integrity preservation with potential impact on prognosis. Additional studies are necessary to determine the citrullinemia value in this context.

REFERENCES

1. Lindberg G. Basic Physiology of Motility, Absorption and Secretion. In: Langnas AN, Goulet O, Quiley EMM, Tappenden KA, editors. Intestinal failure: Diagnosis, management and transplantation. Oxford, UK: Blackwell Publishing, Ltd; 2008. pp. 20-32. [ Links ]

2. O'Mahony L. Immunology of the Small Intestine. In: Langnas AN, Goulet O, Quiley EMM, Tappenden KA, editors. Intestinal Failure: Diagnosis, Management and Transplantation. Oxford, UK: Blackwell Publishing, Ltd; 2008. pp. 33-44. [ Links ]

3. Wiest R, Rath HC. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 2003;17:397-425. [ Links ]

4. Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness. Crit Care Clin 2016;32:203-12. [ Links ]

5. Reintam Blaser A, Jakob SM, Starkopf J. Gastrointestinal failure in the ICU. Curr Opin Crit Care 2016;22:128-41. [ Links ]

6. Piton G, Capellier G. Biomarkers of gut barrier failure in the ICU. Curr Opin Crit Care 2016;22:152-60. [ Links ]

7. Piton G, Belon F, Cypriani B, Regnard J, Puyraveau M, Manzon C, et al. Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality. Crit Care Med 2013;41:2169-76. [ Links ]

8. Reintam Blaser A, Poeze M, Malbrain ML, Björck M, Oudemans-van Straaten HM, et al.; Gastro-Intestinal Failure Trial Group. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study. Intensive Care Med 2013;39:899-909. [ Links ]

9. Reintam A, Parm P, Kitus R, Starkopf J, Kern H. Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care 2008;12:R90. [ Links ]

10. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 2008;27:328-39. [ Links ]

11. Curis E, Crenn P, Cynober L. Citrulline and the gut. Curr Opin Clin Nutr Metab Care 2007;10:620-6. [ Links ]

12. Cynober L. Citrulline: just a biomarker or a conditionally essential amino acid and a pharmaconutrient in critically ill patients? Crit Care 2013;17:122. [ Links ]

13. Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med 2011;37:911-7. [ Links ]

14. Intensive Care Society. Levels of Critical Care for Adult Patients - Intensive Care Society. Available at: http://www.ics.ac.uk/ics-homepage/guidelines-and-standards/. 2014. Assessed in September 23, 2015. [ Links ]

15. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5. [ Links ]

16. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al.; CANONIC Study Investigators of the EASL-CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1426-37. [ Links ]

17. World Medical Association: World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/17c.pdf. 2008. Assessed in September 23, 2015. [ Links ]

18. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993;19:137-44. [ Links ]

19. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63. [ Links ]

20. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al.; on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707-10. [ Links ]

21. Baker SP, O'Neill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-96. [ Links ]

22. Champion HR, Sacco WJ, Copes WS, Gann DS, Gennarelli TA, Flanagan ME. A revision of the Trauma Score. J Trauma 1989;29:623-9. [ Links ]

23. Rady MY, Smithline HA, Blake H, Nowak R, Rivers E. A comparison of the shock index and conventional vital signs to identify acute, critical illness in the emergency department. Ann Emerg Med 1994;24:685-90 [ Links ]

24. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infectin and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32. [ Links ]

25. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 1984;2:187-93. [ Links ]

26. Le Boucher J, Charret C, Coudray-Lucas C, Giboudeau J, Cynober L. Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A. Clin Chem 1997;43:1421-8. [ Links ]

27. Sertaridou E, Papaioannou V, Kolios G, Pneumatikos I. The gut failure in critical care: old school versus new school. Ann Gastroenterol 2015;28:309-322. [ Links ]

28. Schmid-Schönbein GW, Chang M. The autodigestion hypothesis for shock and multi-organ failure. Ann Biomed Eng 2014;42:405-14. [ Links ]

29. Shen LJ, Guan YY, Wu XP, Wang Q, Wang L, Xiao T, et al. Serum citrulline as a diagnostic marker of sepsis-induced intestinal dysfunction. Clin Res Hepatol Gastroenterol 2015;39:230-6. [ Links ]

30. Crenn P, Neveux N, Chevret S, Jaffray P, Cynober L, Melchior JC, et al.; COIITSS Study Group. Plasma L-citrulline concentrations and its relationship with inflammation at the onset of septic shock: a pilot study. J Crit Care 2014;29:315.e1-6. [ Links ]

31. Piton G, Manzon C, Monnet E, Cypriani B, Barbot O, Navellou JC, et al. Plasma citrulline kinetics and prognostic value in critically ill patients. Intensive Care Med 2010;36:702-6. [ Links ]

32. Blasco-Alonso J, Sánchez Yáñez P, Rosa Camacho V, Camacho Alonso JM, Yahyaoui Macías R, Gil-Gómez R, et al. Citrulline and arginine kinetics and its value as a prognostic factor in pediatric critically ill patients. An Pediatr (Barc) 2015;83:257-63. [ Links ]

33. van Waardenburg DA, de Betue CT, Luiking YC, Engel M, Deutz NE. Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. Am J Clin Nutr 2007;86:1438-44. [ Links ]

34. Grimaldi D, Guivarch E, Neveux N, Fichet J, Pène F, Marx JS, et al. Markers of intestinal injury are associated with endotoxemia in successfully resuscitated patients. Resuscitation 2013;84:60-5. [ Links ]

35. Noordally SO, Sohawon S, Semlali H, Michely D, Devriendt J, Gottignies P. Is there a correlation between circulating levels of citrulline and intestinal dysfunction in the critically ill? Nutr Clin Pract 2012;27:527-32. [ Links ]

Received: November 29, 2016; Accepted: January 18, 2017

Correspondence: Beatriz Pinto da Costa. Serviço de Cirurgia A. Hospitais da Universidade de Coimbra. Centro Hospitalar e Universitário de Coimbra. Praceta Prof. Mota Pinto. 3000-075 Coimbra, Portugal e-mail: beatrizpcosta@huc.min-saude.pt

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.